Predictive and prognostic angiogenic markers in a gynecologic oncology group phase II trial of bevacizumab in recurrent and persistent ovarian or peritoneal cancer
| Image |  |
|---|---|
| Description | scientific article published on September 25, 2010 |
| Author/s |
author: Bradley J. Monk |
| Publication date | September 25, 2010 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Access work | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |